Genes with co-alterations notably enriched in KRASm subsets included STK11 in non-Sq NSCLC, PIK3CA and APC in CRC, and ARID1A, PTEN, and PIK3CA in endometrial tumors. This evidence concerns the gene PTEN and non-small cell lung carcinoma.